Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.7 |
mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |